ELOVL2-AS1 inhibits migration of triple negative breast cancer
In this study, we identified a key enhancer RNA (eRNA) region in breast cancer (BRCA) by applying an integrated analysis method. Reported eRNA region and genes affected by them were selected as presumed target pairs. Kaplan–Meier (KM) survival and correlation analyses were performed to screen valuab...
Main Authors: | Mingda Zhu, Jingyang Zhang, Guangyu Li, Zhenzhen Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2022-04-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/13264.pdf |
Similar Items
-
ELOVLs Predict Distinct Prognosis Value and Immunotherapy Efficacy In Patients With Hepatocellular Carcinoma
by: Yu Zhang, et al.
Published: (2022-07-01) -
Influence of Single Nucleotide Polymorphisms of ELOVL on Biomarkers of Metabolic Alterations in the Mexican Population
by: María Luisa Maycotte-Cervantes, et al.
Published: (2020-11-01) -
ELOVL5 and IGFBP6 genes modulate sensitivity of breast cancer cells to ferroptosis
by: Sergey Nikulin, et al.
Published: (2023-01-01) -
DNA methylation of ELOVL2 gene as an epigenetic marker of age among Egyptian population
by: Noha M. El-Shishtawy, et al.
Published: (2024-01-01) -
Disintegrin-like Protein Strategy to Inhibit Aggressive Triple-Negative Breast Cancer
by: Inès Limam, et al.
Published: (2023-07-01)